4.44 0.19 (4.47%)

83.32% Fall from 52W High

94,684 XNAS Volume

XNAS 19 Mar, 2025 5:30 PM (EDT)



Insider Trading disclosures for BioAge Labs Inc.

The latest disclosure was made by Dov A. Goldstein in BioAge Labs Inc. where a trade of 170,000 Stock Option (Right to Buy) done was reported to US exchanges on Feb. 18, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Dov A. Goldstein Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2025 170,000 170,000 - - Stock Option (Right to Buy)
Paul D. Rubin Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2025 200,000 200,000 - - Stock Option (Right to Buy)
Kristen Fortney Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2025 530,000 530,000 - - Stock Option (Right to Buy)
Eric Morgen Director, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2025 200,000 200,000 - - Stock Option (Right to Buy)
Eric Morgen Director, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2025 25,000 25,000 - - Stock Option (Right to Buy)
James I. Healy Director Purchase of securities on an exchange or from another person at price $ 18.00 per share. 25 Sep 2024 26,497 26,497 - 18 476,946 Common Stock
Patrick G. Enright Director 25 Sep 2024 5,848,637 0 - - Series D Preferred Stock
James I. Healy Director Purchase of securities on an exchange or from another person at price $ 18.00 per share. 25 Sep 2024 21,814 21,814 - 18 392,652 Common Stock
James I. Healy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Sep 2024 15,000 15,000 - - Stock Option (Right to Buy)
James I. Healy Director Purchase of securities on an exchange or from another person at price $ 18.00 per share. 25 Sep 2024 18,353 18,353 - 18 330,354 Common Stock
James I. Healy Director 25 Sep 2024 7,310,796 0 - - Series D Preferred Stock
James I. Healy Director Purchase of securities on an exchange or from another person at price $ 18.00 per share. 25 Sep 2024 588,888 2,227,124 - 18 10,599,984 Common Stock
James I. Healy Director Purchase of securities on an exchange or from another person at price $ 18.00 per share. 25 Sep 2024 11,113 11,113 - 18 200,034 Common Stock
James I. Healy Director 25 Sep 2024 1,638,236 1,638,236 - - Common Stock
Patrick G. Enright Director 25 Sep 2024 1,310,589 1,310,589 - - Common Stock
Patrick G. Enright Director Purchase of securities on an exchange or from another person at price $ 18.00 per share. 25 Sep 2024 400,000 1,710,589 - 18 7,200,000 Common Stock
Patrick G. Enright Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Sep 2024 15,000 15,000 - - Stock Option (Right to Buy)
Jean-Pierre Garnier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Aug 2024 15,000 15,000 - - Stock Option (Right to Buy)
Jean-Pierre Garnier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Aug 2024 141,609 141,609 - - Stock Option (Right to Buy)
Rekha Hemrajani Director Purchase of securities on an exchange or from another person at price $ 18.00 per share. 17 Apr 2024 3,000 3,000 - 18 54,000 Common Stock
Eric Morgen Director, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2024 13,598 13,598 - - Stock Option (Right to Buy)
Eric Morgen Director, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2024 257,973 257,973 - - Stock Option (Right to Buy)
Eric Morgen Director, Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2024 4,952 4,952 - - Stock Option (Right to Buy)
Kristen Fortney Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2024 708,044 708,044 - - Stock Option (Right to Buy)
Kristen Fortney Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2024 424,827 424,827 - - Stock Option (Right to Buy)
Rekha Hemrajani Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2024 15,000 15,000 - - Stock Option (Right to Buy)
Rekha Hemrajani Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2024 28,497 28,497 - - Stock Option (Right to Buy)
Michael Harvey Davidson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2024 15,000 15,000 - - Stock Option (Right to Buy)
Michael Harvey Davidson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2024 33,986 33,986 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures